About Us: CAPEBIO is a South African biotech firm that manufactures “best-in-class” molecular biology research and diagnostics assays or In Vitro Diagnostics (IVDs). We leverage our bio-discovery AI platform to develop a wide range of molecular diagnostics platforms for fast and accurate detection of pathogens. Vision: To create excellent innovations that improve quality of life in Africa and beyond. Mission: To leverage our innovative bio-discovery R&D to share the benefits of molecular enzymes sourced from indigenous African microbial hotspots with our clients and partners locally - and across the globe. Products & Services: For more information regarding our unique product range, as well as our end-user specific services and after-sales support, please visit our website (https://www.capebiosa.com) or contact us directly (sales@capebiosa.com). Alternatively, contact (+27) 12 665 2600.
| Website | https://www.capebiosa.com |
| Employees | 13 (5 on RocketReach) |
| Founded | 2018 |
| Phone | +27 12 844 0440 |
| Industry | Biotechnology, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies |
Looking for a particular Capebio employee's phone or email?
Daniel Ndima is the CEO of Capebio.
5 people are employed at Capebio.
Capebio is based in Pretoria, Gauteng.
The NAICS codes for Capebio are [54, 541, 5417, 541713, 54171].
The SIC codes for Capebio are [873, 87].